Related Experiment Video
Updated: Jun 16, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Steno-sphere: Navigating the enigmatic world of emerging multidrug-resistant Stenotrophomonas maltophilia
Ashlan J Kunz Coyne1, Shelbye Herbin2, Kaylee Caniff1
1Anti-Infective Research Laboratory, College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
Abstract:
Stenotrophomonas maltophilia is an opportunistic pathogen and frequent cause of serious nosocomial infections. Patient populations at greatest risk for these infections include the immunocompromised and those with chronic respiratory illnesses and prior antibiotic exposure, notably to carbapenems. Its complex virulence and resistance profile drastically limit available antibiotics, and incomplete breakpoint and pharmacokinetic/pharmacodynamic (PK/PD) data to inform dose optimization further complicates therapeutic approaches. Clinical comparison data of first-line agents, including trimethoprim-sulfamethoxazole (TMP-SMX), quinolones, and minocycline, are limited to conflicting observational data with no clear benefit of a single agent or combination therapy. Newer antibiotic approaches, including cefiderocol and aztreonam- avibactam, are promising alternatives for extensively drug-resistant isolates; however, clinical outcomes data are needed. The potential clinical utility of bacteriophage for compassionate use in treating S. maltophilia infections remains to be determined since data is limited to in-vitro and sparse in-vivo work. This article provides a review of available literature for S. maltophilia infection management focused on related epidemiology, resistance mechanisms, identification, susceptibility testing, antimicrobial PK/PD, and emerging therapeutic strategies.
Insights
Stenotrophomonas maltophilia infections are challenging due to limited treatment options and complex resistance. This review examines current and emerging strategies for managing these serious nosocomial infections.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Stenotrophomonas maltophilia is a significant opportunistic pathogen causing nosocomial infections, particularly in immunocompromised individuals.
- High rates of antibiotic resistance, especially to carbapenems, complicate treatment, necessitating a review of therapeutic strategies.
- Limited clinical data on first-line agents and emerging therapies hinder optimal patient management.
Purpose of the Study:
- To review the epidemiology, resistance mechanisms, and diagnostic approaches for Stenotrophomonas maltophilia infections.
- To evaluate current and emerging antimicrobial therapies, including PK/PD data and novel agents.
- To provide a comprehensive overview for optimizing the management of S. maltophilia infections.
Main Methods:
- Literature review of epidemiology, resistance, diagnostics, and therapeutics for S. maltophilia.
- Analysis of clinical comparison data for first-line antibiotics (TMP-SMX, quinolones, minocycline).
- Assessment of newer agents (cefiderocol, aztreonam-avibactam) and bacteriophage therapy.
Main Results:
- Conflicting observational data exist for first-line agents, with no clear preferred monotherapy or combination.
- Emerging antibiotics like cefiderocol and aztreonam-avibactam show promise for drug-resistant strains, but require more outcome data.
- Bacteriophage therapy for S. maltophilia infections is largely unexplored, with limited in-vitro and in-vivo evidence.
Conclusions:
- Effective management of S. maltophilia infections requires understanding its complex resistance and virulence.
- Further clinical outcome data are crucial for guiding the use of novel antimicrobial agents.
- Comprehensive strategies integrating diagnostics, PK/PD, and emerging therapies are needed to combat these challenging infections.
More Related Videos
Related Concept Videos
Special Staining Techniques
Deep Sea Microbial Ecology
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

